MATSUO Kazuhiko

マツオカズヒコ | MATSUO Kazuhiko

Affiliation and department：
Homepage URL (1)： http://kaken.nii.ac.jp/d/r/70615921.ja.html

Research field (2)： Infectious disease , Clinical pharmacy

Research keywords (6)：免疫記憶 , ワクチンアジュバント , ケモカイン , 自己溶解型マイクロニードル , 経皮ワクチン , アルツハイマー病

Research theme for competitive and other funds (8)：

2023 - 2026 ケモカインCCL28の好酸球を介したメラノーマ腫瘍免疫における役割
2020 - 2023 乾癬におけるケモカイン受容体CCR4を介したTh17細胞増殖の病理的役割の解明
2020 - 2023 Memory CTL-inducing vaccine sistem targeting P2 recepors
2017 - 2020 Identification of a novel receptor for ELC/CCL19 and its role in psoriasis
2015 - 2017 Establishment of skin inflammation drug to accumulate high-functional regulatory T cells by single-cell gene expression analysis

Show all

Papers (63)：

Momo Kamei, Kazuhiko Matsuo, Yusuke Yoshida, Kaho Shimada, Mayuko Otsuki, Nao Fujimoto, Miho Ishibashi, Ying-Shu Quan, Fumio Kamiyama, Yuta Hara, et al. Intratumoral delivery of a highly active form of XCL1 enhances antitumor CTL responses through recruitment of CXCL9-expressing conventional type-1 dendritic cells. International journal of cancer. 2024. 154. 12. 2176-2188
Haruo Ohtani, Kazuhiko Matsuo, Kosuke Kitahata, Eiichi Sato, Takashi Nakayama. C-C Chemokine 21-Expressing T-cell Zone Fibroblastic Reticular Cells, Abundant in Lymph Nodes, Are Absent in Cancer Lymphoid Stroma. Acta histochemica et cytochemica. 2024. 57. 2. 67-74
Yuichiro Kaibori, Saho Tamoto, Sayoko Okuda, Kazuhiko Matsuo, Takashi Nakayama, Daisuke Nagakubo. CCL28: A Promising Biomarker for Assessing Salivary Gland Functionality and Maintaining Healthy Oral Environments. Biology. 2024. 13. 3
Yuta Hara, Tatsuma Honzawa, Moeka Kitagawa, Ritsuki Sano, Kazuhiko Matsuo, Takashi Nakayama. Aggravation of lipopolysaccharide-induced depressive-like behavior in CCR4-deficient mice. Journal of Pharmacological Sciences. 2023. 153. 3. 89-93
Masako Sato, Kazuhiko Matsuo, Yoko Susami, Ayaka Yamashita, Haruko Hayasaka, Yuta Hara, Keiji Nishiwaki, Naoki Oiso, Akira Kawada, Atsushi Otsuka, et al. A CCR4 antagonist attenuates atopic dermatitis-like skin inflammation by inhibiting the recruitment and expansion of Th2 cells and Th17 cells. International Immunology. 2023. 35. 9. 437-446

ｍore...

MISC (65)：

山下絢香, 松尾一彦, 須佐美陽子, 早坂晴子, 原雄大, 中山隆志. CCR4 antagonist ameliorated atopi dermatitis by inhibiting infiltration and expansion of CCR4-expressing Th2 cells and Th17 cells in mice. 日本薬学会年会要旨集(Web). 2023. 143rd
西田晃尚, 山本真也, 松尾一彦, 早坂晴子, 海堀祐一郎, 長久保大輔, 原雄大, 義江修, 義江修, 中山隆志. Chemokine CCL28-mediated antitumor immunity against a murine melanoma. 日本薬学会年会要旨集(Web). 2023. 143rd
坂本裕介, 萬瀬貴昭, 楡光世, 綿原光司, 原雄大, 松尾一彦, 中山隆志, 森川敏生, 森川敏生. Neolignan from the fruit of Alpinia galanga as antagonists of CC chemokine receptor-3. 日本農芸化学会大会講演要旨集(Web). 2022. 2022
森川敏生, 森川敏生, 萬瀬貴昭, 坂本祐介, 綿原光司, 原雄大, 松尾一彦, 中山隆志. 紅豆こう(Alpinia galanga,果実)ケモカイン受容体CCR3選択的アンタゴニスト作用を指標とした抗アレルギー作用成分の探索. 日本生薬学会年会講演要旨集. 2021. 67th
松尾一彦, 中山隆志. 細胞遊走. ファルマシア. 2020. 56. 4. 335_2-335_2

ｍore...

Books (6)：

応用が拡がるDDS - 人体環境から農業・家電まで -
エヌ・ティー・エス 2013
Bio-Nanotechnology: A Revolution in Food, Biomedical and Health Sciences
Wiley-Blackwell 2013
ドラッグデリバリーシステムの新展開II - 核酸医薬・抗体医薬・ワクチン医療を支えるDDS技術
シーエムシー出版 2012
次世代バイオ医薬品の製剤設計と開発戦略
シーエムシー出版 2011
次世代経皮吸収型製剤の開発と応用
シーエムシー出版 2011

ｍore...

Professional career (1)：

Work history (4)：

Awards (2)：

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page